Breast cancer, with its myriad subtypes, has long eluded a uniform treatment strategy. The disease’s molecular complexity has rendered traditional, blanket treatments insufficient, particularly for the aggressive triple-negative form.
Just – Evotec Biologics expands tech partnership for biosimilars with Sandoz – Biotech Investments
EQS-News: Evotec SE / Key word(s): Miscellaneous Just – Evotec Biologics expands tech partnership for biosimilars with Sandoz 08.07.2024 / 14:00 CET/CEST The issuer is